[Form 4] Evolus, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Stewart Brady, a director of Evolus, Inc. (EOLS), purchased 30,000 shares of the issuer's common stock on 08/15/2025 at a weighted average price of $6.8162 per share, increasing his beneficial ownership to 88,629 shares. The Form 4 reports the shares were bought in multiple trades at prices ranging from $6.7699 to $6.82, and the filing was signed by Jeffrey J. Plumer as attorney-in-fact on 08/18/2025. The transaction is reported as a purchase and the ownership is listed as direct.

Insights

Financial Analyst

TL;DR: Director purchased 30,000 shares at a weighted average of $6.8162, raising direct holdings to 88,629 shares.

The purchase increases the director's direct stake and signals a meaningful personal investment at recent market prices. The reported weighted average price and the disclosed trade price range provide transparency on execution costs. Without information on total outstanding shares or prior ownership percentage, the absolute impact on shareholder alignment and dilution cannot be determined from this filing alone.

Corporate Governance Expert

TL;DR: Form 4 shows a clear, properly executed insider purchase reported by attorney-in-fact.

The filing presents required disclosures: transaction date, quantity, weighted average price, and resulting beneficial ownership. The signature by an attorney-in-fact is noted and the explanatory footnote supplies the trade price range. The document contains the necessary items for Section 16 transparency; it does not, however, include any contractual plan designation or other governance actions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stewart Brady

(Last) (First) (Middle)

520 NEWPORT CENTER DRIVE

SUITE 1200

(Street)

NEWPORT BEACH CA 92660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Evolus, Inc. [ EOLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		P		30,000	A	$6.8162(1)	88,629	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were purchased in multiple trades at prices ranging from $6.7699 to $6.82. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Jeffrey J. Plumer, as attorney-in-fact for Brady Stewart	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Evolus (EOLS) director Stewart Brady report on Form 4?

The director reported a purchase of 30,000 shares on 08/15/2025.

At what price were the shares bought according to the Form 4 for EOLS?

The filing lists a weighted average purchase price of $6.8162 and a trade range of $6.7699 to $6.82.

How many shares does Stewart Brady beneficially own after the reported transaction?

Following the purchase, the filing reports beneficial ownership of 88,629 shares.

When was the Form 4 for this transaction signed and who signed it?

The Form 4 was signed by Jeffrey J. Plumer, as attorney-in-fact for Brady Stewart, dated 08/18/2025.

Is the reported ownership listed as direct or indirect on the Form 4?

The filing indicates the ownership form as Direct.